Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors
PH12021551669B1Active Publication Date: 2026-09-16ESCAPE THERAPEUTICS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12021551669
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-07-12
- Publication Date
- 2026-09-16
- Estimated Expiration
- 2041-07-12
Abstract
Embodiments relate to tyrosine inhibitors that exhibit immunosuppressive activity in human neonatal keratinocyte progenitors. Particular embodiments feature the immunosuppressive effects of a decapeptide and / or oxyresveratrol, as measured by two different methods: blockade of stimulated cell growth, and inhibition of cytotoxic killing.
Need to check novelty before this filing date? Find Prior Art